Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MAHLUM, JONATHAN DAVIS | 1 | 51.6% | +21.2% |
| HAMMELL, NEIL P | 1 | 34.6% | +43.0% |
| GU, QINHUA | 1 | 77.3% | +27.6% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 39.3% | +70.3% |
| JOHANSEN, PETER N. | 1 | 59.1% | +23.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17914872 | SMALL MOLECULES INDUCING THE DEGRADATION OF THE CELLULAR PRION PROTEIN | MAHLUM, JONATHAN DAVIS | 1d overdue |
| 17285356 | INTEIN PROTEINS AND USES THEREOF | GU, QINHUA | — |
| 17284160 | SELECTION BY MEANS OF ARTIFICIAL TRANSACTIVATORS | LIPPOLIS, ALEXANDRA ROSE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17914872 | SMALL MOLECULES INDUCING THE DEGRADATION OF THE CELLULAR PRION PROTEIN | MAHLUM, JONATHAN DAVIS | 1d overdue |
| 17602918 | METHOD FOR ANALYSING INSERTION SITES | HAMMELL, NEIL P | — |
| 17285356 | INTEIN PROTEINS AND USES THEREOF | GU, QINHUA | — |
| 17284160 | SELECTION BY MEANS OF ARTIFICIAL TRANSACTIVATORS | LIPPOLIS, ALEXANDRA ROSE | — |
| 16604484 | GENE THERAPY | JOHANSEN, PETER N. | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1681 | 1 |
| 1633 | 1 |
| 1637 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17914872 | SMALL MOLECULES INDUCING THE DEGRADATION OF THE CELLULAR PRION PROTEIN | MAHLUM, JONATHAN DAVIS | 1625 | §102§112 | Non-Final OA | 1d overdue | Pending | Sep 27, 2022 |
| 17602918 | METHOD FOR ANALYSING INSERTION SITES | HAMMELL, NEIL P | 1681 | §103 | Non-Final OA | — | Pending | Oct 11, 2021 |
| 17285356 | INTEIN PROTEINS AND USES THEREOF | GU, QINHUA | 1633 | §103§112 | Final Rejection | — | Pending | Apr 14, 2021 |
| 17284160 | SELECTION BY MEANS OF ARTIFICIAL TRANSACTIVATORS | LIPPOLIS, ALEXANDRA ROSE | 1637 | §102§103 | Final Rejection | — | Pending | Apr 09, 2021 |
| 16604484 | GENE THERAPY | JOHANSEN, PETER N. | 1644 | §103 | Non-Final OA | — | Pending | Oct 10, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial